Schedule of activities | |||||
---|---|---|---|---|---|
Gastrointestinal Tumors | |||||
Enrollment | Initial Visit and chemotherapy cycle 1 | Cycle 2 | Cycle 3 | Close-out | |
Time point | Week 1 | Week 2 | Week 6 | Week 10 | Week 12 -14 |
Enrolment | |||||
Screening and Informed Consent | X | ||||
Physical Examen | X | X | X | X | |
Clinical Record | X | X | X | X | |
HIV Test and Pregnancy test | X | ||||
Interventions | |||||
Medication dispensing | X | X | X | X | |
Follow-up visit | X | X | X | X | |
Safety Assessment | |||||
Hemogram | X | X | |||
Transaminase AST | X | X | |||
Transaminase ALT | X | X | |||
Alkaline Phosphatase | X | X | |||
Total Bilirubin | X | X | |||
Triglycerides | X | X | |||
Total Cholesterol | X | X | |||
Blood Urea Nitrogen (BUN) | X | X | |||
Creatinine | X | X | |||
Urinalysis | X | X | |||
Uric Acid | X | X | |||
LDH (Lactate Dehydrogenase) | X | X | |||
Lactic Acid | X | X | |||
Ferritin | X | X | |||
Albumin | X | X | |||
Iron | X | X | |||
Electrocardiogram | X | X | |||
Echocardiogram | X | X | |||
Efficacy Assessment | |||||
RECIST | X | X | |||
Tumor Antigens | X | X | |||
CA199 | X | X | |||
ACE | X | X | |||
Metabolome | X | X | X | ||
Microbiome Analysis | X | X | |||
Proinflammatory Cytokines | X | X | X | ||
Circulating DNA | X | X | X | ||
Ketone Bodies | X | X | X | ||
Tumor Infiltration | X | X | |||
QLQ C-30 Quality of Life Surveys | X | X | X | X | |
Progression-Free Survival | X | X |